Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 22 , ISSUE 12 ( 2018 ) > List of Articles


Extracorporeal treatment in the management of acute poisoning: What an intensivist should know?

Vijoy Jha, K. V. Padmaprakash

Keywords : End-stage kidney disease, extracorporeal treatment, hemoperfusion, intermittent hemodialysis

Citation Information : Jha V, Padmaprakash KV. Extracorporeal treatment in the management of acute poisoning: What an intensivist should know?. Indian J Crit Care Med 2018; 22 (12):862-869.

DOI: 10.4103/ijccm.IJCCM_425_18

License: CC BY-ND 3.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2018; The Author(s).


Extracorporeal treatment (ECTR) represents a treatment modality promoting removal of endogenous or exogenous poisons and supporting or temporarily replacing a vital organ. This article aims to provide a brief overview of the technical aspects and the potential indications and limitations of the different ECTRs, highlighting the important characteristics of poison amenable to ECTR and the most appropriate prescriptions used in the setting of acute poisoning. The various principles that govern poison elimination by ECTR (diffusion, convection, adsorption, and centrifugation) and how components of the ECTR can be adjusted to maximize clearance have also being discussed.

PDF Share
  1. Mowry JB, Spyker DA, Cantilena LR Jr., Bailey JE, Ford M. 2012 Annual Report of the American Association of poison control centers' national poison data system (NPDS): 30th annual report. Clin Toxicol (Phila) 2013;51:949-1229.
  2. Abel JJ, Rowntree LG, Turner BB. On the removal of diffusable substances from the circulating blood by means of dialysis. Transactions of the Association of American Physicians, 1913. Transfus Sci 1990;11:164-5.
  3. Lavergne V, Nolin TD, Hoffman RS, Roberts D, Gosselin S, Goldfarb DS, et al. The EXTRIP (EXtracorporeal TReatments in poisoning) workgroup: Guideline methodology. Clin Toxicol (Phila) 2012;50:403-13.
  4. Hauk M, Kuhlmann MK, Riegel W, Köhler H. In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients. Am J Kidney Dis 2000;35:105-11.
  5. Leypoldt JK, Cheung AK. Removal of high-molecular-weight solutes during high-efficiency and high-flux haemodialysis. Nephrol Dial Transplant 1996;11:329-35.
  6. Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J, et al. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999;34:486-92.
  7. Gong D, Ji D, Xie H, Xu B, Liu Y, Li L, et al. The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy. Zhonghua Nei Ke Za Zhi 2001;40:183-6.
  8. Powers KM, Wilkowski MJ, Helmandollar AW, Koenig KG, Bolton WK. Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel. Am J Kidney Dis 2000;35:266-74.
  9. Churchwell MD, Pasko DA, Smoyer WE, Mueller BA. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant 2009;24:231-8.
  10. Kan G, Jenkins I, Rangan G, Woodroffe A, Rhodes H, Joyce D, et al. Continuous haemodiafiltration compared with intermittent haemodialysis in the treatment of methanol poisoning. Nephrol Dial Transplant 2003;18:2665-7.
  11. Wizemann V, Kulz M, Teichert F, Nederlof B. Efficacy of haemodiafiltration. Nephrol Dial Transplant 2001;16:27-30.
  12. Colussi G, Frattini G. Quantitative analysis of convective dose in hemofiltration and hemodiafiltration: “predilution” vs. “postdilution” reinfusion. Hemodial Int 2007;11:76-85.
  13. Pellicano R, Polkinghorne KR, Kerr PG. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: Results of a 6-week, randomized, double-blind, crossover trial. Am J Kidney Dis 2008;52:93-101.
  14. Ward RA. Protein-leaking membranes for hemodialysis: A new class of membranes in search of an application? J Am Soc Nephrol 2005;16:2421-30.
  15. Hazouard E, Ferrandiere M, Rateau H, Doucet O, Perrotin D, Legras A. Continuous veno-venous haemofiltration versus continuous venovenous hemodialysis in severe lithium self-poisoning: A toxicokinetics study in an intensive care unit. Nephrol Dial Transplant 1999;14:1605-6.
  16. Lornoy W, De Meester J, Becaus I, Billiouw JM, Van Malderen PA, Van Pottelberge M, et al. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr 2006;16:47-53.
  17. Roberts DM, Yates C, Megarbane B, Winchester JF, Maclaren R, Gosselin S, et al. Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: A systematic review and consensus statement. Crit Care Med 2015;43:461-72.
  18. Liao Z, Zhang W, Hardy PA, Poh CK, Huang Z, Kraus MA, et al. Kinetic comparison of different acute dialysis therapies. Artif Organs 2003;27:802-7.
  19. Amdisen A. Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet 1977;2:73-92.
  20. Goodman JW, Goldfarb DS. The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial 2006;19:402-7.
  21. Yamashita AC. Mechanisms of solute and fluid removal in hemodiafiltration. Contrib Nephrol 2007;158:50-6.
  22. Ghannoum M, Bouchard J, Nolin TD, Ouellet G, Roberts DM. Hemoperfusion for the treatment of poisoning: Technology, determinants of poison clearance, and application in clinical practice. Semin Dial 2014;27:350-61.
  23. Rahman MH, Haqqie SS, McGoldrick MD. Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion. Hemodial Int 2006;10:256-9.
  24. Falkenhagen D, Gottschall S, Esther G, Courtney JM, Klinkmann H. In vitro assessment of charcoal and resin hemoadsorbents. Contrib Nephrol 1982;29:23-33.
  25. Mydlík M, Derzsiová K, Bucek J, Horký K, Jarcuska J, Takác M, et al. Use of charcoal haemoperfusion in 55 acute poisonings. Life Support Syst 1983;1 Suppl 1:53-6.
  26. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, et al. Guidelines on the use of therapeutic apheresis in clinical practice – Evidence-based approach from the apheresis applications committee of the American Society for Apheresis. J Clin Apher 2010;25:83-177.
  27. Hastings D, Patel B, Torloni AS, Mookadam F, Betcher J, Moss A, et al. Plasmapheresis therapy for rare but potentially fatal reaction to rituximab. J Clin Apher 2009;24:28-31.
  28. Jones JS, Dougherty J. Current status of plasmapheresis in toxicology. Ann Emerg Med 1986;15:474-82.
  29. Lee CS, Peterson JC, Marbury TC. Comparative pharmacokinetics of theophylline in peritoneal dialysis and hemodialysis. J Clin Pharmacol 1983;23:274-80.
  30. Ouellet G, Bouchard J, Ghannoum M, Decker BS. Available extracorporeal treatments for poisoning: Overview and limitations. Semin Dial 2014;27:342-9.
  31. Lionte C, Sorodoc L, Simionescu V. Successful treatment of an adult with amanita phalloides-induced fulminant liver failure with molecular adsorbent recirculating system (MARS). Rom J Gastroenterol 2005;14:267-71.
  32. Ghannoum M, Hoffman RS, Gosselin S, Nolin TD, Lavergne V, Roberts DM, et al. Use of extracorporeal treatments in the management of poisonings. Kidney Int 2018;94:682-8.
  33. Wolley M, Jardine M, Hutchison CA. Exploring the clinical relevance of providing increased removal of large middle molecules. Clin J Am Soc Nephrol 2018;13:805-14.
  34. Kirsch AH, Lyko R, Nilsson LG, Beck W, Amdahl M, Lechner P, et al. Performance of hemodialysis with novel medium cut-off dialyzers. Nephrol Dial Transplant 2017;32:165-72.
  35. Lee S, Johnson D, Klein J, Eppler J. Protein binding of acetylsalicylic acid and salicylic acid in porcine and human serum. Vet Hum Toxicol 1995;37:224-5.
  36. Calello DP, Liu KD, Wiegand TJ, Roberts DM, Lavergne V, Gosselin S, et al. Extracorporeal treatment for metformin poisoning: Systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med 2015;43:1716-30.
  37. Ghannoum M, Lavergne V, Gosselin S, Mowry JB, Hoegberg LC, Yarema M, et al. Practice trends in the use of extracorporeal treatments for poisoning in four countries. Semin Dial 2016;29:71-80.
  38. Lavergne V, Hoffman RS, Mowry JB, Cormier M, Gosselin S, Roberts DM, et al. Why are we still dialyzing overdoses to tricyclic antidepressants? A subanalysis of the NPDS database. Semin Dial 2016;29:403-9.
  39. Bouchard J, Roberts DM, Roy L, Ouellet G, Decker BS, Mueller BA, et al. Principles and operational parameters to optimize poison removal with extracorporeal treatments. Semin Dial 2014;27:371-80.
  40. Roberts DM, Buckley NA. Pharmacokinetic considerations in clinical toxicology: Clinical applications. Clin Pharmacokinet 2007;46:897-939.
  41. Baird-Gunning J, Lea-Henry T, Hoegberg LCG, Gosselin S, Roberts DM. Lithium poisoning. J Intensive Care Med 2017;32:249-63.
  42. Amdisen A, Skjoldborg H. Haemodialysis for lithium poisoning. Lancet 1969;2:213.
  43. The Extracorporeal Treatments in Poisoning Workgroup. Available from: [Last accessed on 2018 Dec 09].
  44. Yates C, Galvao T, Sowinski KM, Mardini K, Botnaru T, Gosselin S, et al. Extracorporeal treatment for tricyclic antidepressant poisoning: Recommendations from the EXTRIP workgroup. Semin Dial 2014;27:381-9.
  45. Mowry JB, Burdmann EA, Anseeuw K, Ayoub P, Ghannoum M, Hoffman RS, et al. Extracorporeal treatment for digoxin poisoning: Systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) 2016;54:103-14.
  46. Palmer BF. Effectiveness of hemodialysis in the extracorporeal therapy of phenobarbital overdose. Am J Kidney Dis 2000;36:640-3.
  47. Proudfoot AT, Stewart MS, Levitt T, Widdop B. Paraquat poisoning: Significance of plasma-paraquat concentrations. Lancet 1979;2:330-2.
  48. Blanco-Ayala T, Andérica-Romero AC, Pedraza-Chaverri J. New insights into antioxidant strategies against paraquat toxicity. Free Radic Res 2014;48:623-40.
  49. Leblanc M, Raymond M, Bonnardeaux A, Isenring P, Pichette V, Geadah D, et al. Lithium poisoning treated by high-performance continuous arteriovenous and venovenous hemodiafiltration. Am J Kidney Dis 1996;27:365-72.
  50. DeLima LG, Kharasch ED, Butler S. Successful pharmacologic treatment of massive atenolol overdose: Sequential hemodynamics and plasma atenolol concentrations. Anesthesiology 1995;83:204-7.
  51. Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA; American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 2002;40:415-46.
  52. Barceloux DG, Krenzelok EP, Olson K, Watson W. American Academy of clinical toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad hoc committee. J Toxicol Clin Toxicol 1999;37:537-60.
  53. Heath A, Knudsen K. Role of extracorporeal drug removal in acute theophylline poisoning. A review. Med Toxicol Adverse Drug Exp 1987;2:294-308.
  54. Hootkins R Sr., Lerman MJ, Thompson JR. Sequential and simultaneous “in series” hemodialysis and hemoperfusion in the management of theophylline intoxication. J Am Soc Nephrol 1990;1:923-6.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.